High expression of CD73 as a poor prognostic biomarker in human colorectal cancer
2012 · Journal of Surgical Oncology · 170 citations
https://doi.org/10.1002/jso.23056
Y
Yifeng Zou
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
124
Papers
1.9K
Citations
25
h-index
39
i10-index
Yifeng Zou is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Colorectal Cancer Surgical Treatments & Genetic factors in colorectal cancer. The author has an h-index of 25, co-authored 106 publications.
ORCID: 0000-0002-0226-6924Papers by this author
worksHES1 promotes metastasis and predicts poor survival in patients with colorectal cancer
2015 · Clinical & Experimental Metastasis · 56 citations
https://doi.org/10.1007/s10585-015-9700-y
Tumor-secreted IFI35 promotes proliferation and cytotoxic activity of CD8+ T cells through PI3K/AKT/mTOR signaling pathway in colorectal cancer
2023 · Journal of Biomedical Science · 48 citations
https://doi.org/10.1186/s12929-023-00930-6
Correlation between altered gut microbiota and elevated inflammation markers in patients with Crohn’s disease
2022 · Frontiers in Immunology · 46 citations
https://doi.org/10.3389/fimmu.2022.947313
A signature of hypoxia-related factors reveals functional dysregulation and robustly predicts clinical outcomes in stage I/II colorectal cancer patients
2019 · Cancer Cell International · 26 citations
https://doi.org/10.1186/s12935-019-0964-1
Conversion is a risk factor for postoperative anastomotic leak in rectal cancer patients - A retrospective cohort study
2018 · International Journal of Surgery · 16 citations
https://doi.org/10.1016/j.ijsu.2018.01.024
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat